
ARTBIO
Operator of a radiopharmaceutical company intended to offer a new approach to the treatment of cancer. The company specializes in radioligand therapy, which delivers alpha or beta emitters to break do...
Valuation
$0
Share Price
N/A
Total Raised
$245M
Last Round
N/A